Literature DB >> 28060028

Kinetics of Angiogenic Responses in Corneal Transplantation.

Takenori Inomata1, Alireza Mashaghi, Antonio Di Zazzo, Sang-Mok Lee, Homer Chiang, Reza Dana.   

Abstract

PURPOSE: To delineate and compare the kinetics of corneal angiogenesis after high-risk (HR) versus low-risk (LR) corneal transplantation.
METHODS: In mice, intrastromal sutures were placed in the recipient graft bed 2 weeks before allogeneic transplantation to induce angiogenesis and amplify the risk of graft rejection. Control (LR) graft recipients did not undergo suture placement, and thus the host bed remained avascular at the time of transplantation. Graft hemangiogenesis and opacity scores were evaluated for 8 weeks by slit-lamp biomicroscopy. Immunohistochemistry was used to measure CD31 (blood vessels) and LYVE-1 (lymphatic vessels) cells.
RESULTS: Biphasic kinetics were observed for hemangiogenesis in both HR and LR transplant recipients using clinical and immunohistochemical assessments. The biphasic kinetics were composed of a rise-fall (phase 1) followed by a second rise (phase 2) in the degree of vessels. Compared with LR recipients, HR recipients showed higher hemangiogenesis (whole cornea and graft) throughout 8 weeks. Analyzing grafts revealed sustained presence of lymphatic vessels in HR recipients; however, lymphatic neovessels regressed in LR recipients 2 weeks posttransplantation. In contrast to HR host beds, the LR host bed microenvironment cannot sustain the growth of lymphatic neovessels in allografts, whereas it can sustain continued hemangiogenesis.
CONCLUSIONS: The sustained presence of lymphatic vessels in HR host beds can facilitate host immunity against allografts and is likely associated with ongoing higher risk of rejection of these grafts in the long term, suggesting that therapeutic interventions targeting inflammation and lymphatic vessels need to be sustained long term in the HR corneal transplant setting.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28060028      PMCID: PMC5334361          DOI: 10.1097/ICO.0000000000001127

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  30 in total

1.  Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages.

Authors:  Kazuichi Maruyama; Masaaki Ii; Claus Cursiefen; David G Jackson; Hiroshi Keino; Minoru Tomita; Nico Van Rooijen; Hideya Takenaka; Patricia A D'Amore; Joan Stein-Streilein; Douglas W Losordo; J Wayne Streilein
Journal:  J Clin Invest       Date:  2005-09       Impact factor: 14.808

Review 2.  Phenotypic transitions of macrophages orchestrate tissue repair.

Authors:  Margaret L Novak; Timothy J Koh
Journal:  Am J Pathol       Date:  2013-09-30       Impact factor: 4.307

3.  E-Selectin Mediates Immune Cell Trafficking in Corneal Transplantation.

Authors:  Thomas H Dohlman; Antonio Di Zazzo; Masahiro Omoto; Jing Hua; Julia Ding; Pedram Hamrah; Sunil K Chauhan; Reza Dana
Journal:  Transplantation       Date:  2016-04       Impact factor: 4.939

4.  Proangiogenic Function of T Cells in Corneal Transplantation.

Authors:  Antonio Di Zazzo; Maryam Tahvildari; Brinda Subbarayal; Jia Yin; Thomas H Dohlman; Takenori Inomata; Alireza Mashaghi; Sunil K Chauhan; Reza Dana
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

Review 5.  Targeting the tumour vasculature: insights from physiological angiogenesis.

Authors:  Alicia S Chung; John Lee; Napoleone Ferrara
Journal:  Nat Rev Cancer       Date:  2010-07       Impact factor: 60.716

6.  Topical interleukin 1 receptor antagonist promotes corneal transplant survival.

Authors:  M R Dana; J Yamada; J W Streilein
Journal:  Transplantation       Date:  1997-05-27       Impact factor: 4.939

Review 7.  Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin).

Authors:  William Stevenson; Sheng-Fu Cheng; Mohammad H Dastjerdi; Giulio Ferrari; Reza Dana
Journal:  Ocul Surf       Date:  2012-01-25       Impact factor: 5.033

8.  Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis.

Authors:  Wei-Li Chen; Chung-Tien Lin; Nien-Ting Lin; I-Hua Tu; Jing-Wen Li; Lu-Ping Chow; Kwan-Rong Liu; Fung-Rong Hu
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-11-07       Impact factor: 4.799

9.  Ocular surgical models for immune and angiogenic responses.

Authors:  Takenori Inomata; Alireza Mashaghi; Antonio Di Zazzo; Reza Dana
Journal:  J Biol Methods       Date:  2015-09-21

10.  Proteolytically Derived Endogenous Angioinhibitors Originating from the Extracellular Matrix.

Authors:  Chandra Shekhar Boosani; Yakkanti A Sudhakar
Journal:  Pharmaceuticals (Basel)       Date:  2011-12
View more
  19 in total

Review 1.  LncRNAs in ocular neovascularizations.

Authors:  Yacouba Cissé; Lang Bai; Min-Ting Chen
Journal:  Int J Ophthalmol       Date:  2019-12-18       Impact factor: 1.779

2.  Use of Post-transplant Cyclophosphamide Treatment to Build a Tolerance Platform to Prevent Liquid and Solid Organ Allograft Rejection.

Authors:  Casey O Lightbourn; Dietlinde Wolf; Sabrina N Copsel; Ying Wang; Brent J Pfeiffer; Henry Barreras; Cameron S Bader; Krishna V Komanduri; Victor L Perez; Robert B Levy
Journal:  Front Immunol       Date:  2021-03-02       Impact factor: 7.561

3.  Promotion of corneal angiogenesis by sensory neuron-derived calcitonin gene-related peptide.

Authors:  Shuyan Zhu; Asmaa Zidan; Kunpeng Pang; Aytan Musayeva; Qianyan Kang; Jia Yin
Journal:  Exp Eye Res       Date:  2022-05-23       Impact factor: 3.770

4.  Regulatory T cells promote corneal endothelial cell survival following transplantation via interleukin-10.

Authors:  Giulia Coco; William Foulsham; Takeshi Nakao; Jia Yin; Afsaneh Amouzegar; Yukako Taketani; Sunil K Chauhan; Reza Dana
Journal:  Am J Transplant       Date:  2019-10-30       Impact factor: 8.086

5.  Sensory neurons directly promote angiogenesis in response to inflammation via substance P signaling.

Authors:  Lingjia Liu; Reza Dana; Jia Yin
Journal:  FASEB J       Date:  2020-03-12       Impact factor: 5.834

6.  Immunophysical analysis of corneal neovascularization: mechanistic insights and implications for pharmacotherapy.

Authors:  Youness Azimzade; Jiaxu Hong; Alireza Mashaghi
Journal:  Sci Rep       Date:  2017-09-22       Impact factor: 4.379

Review 7.  Decoding Noncoding RNAs: Role of MicroRNAs and Long Noncoding RNAs in Ocular Neovascularization.

Authors:  Yan Zhang; Siwei Cai; Yurong Jia; Chen Qi; Jing Sun; Hong Zhang; Fei Wang; Yunshan Cao; Xiaorong Li
Journal:  Theranostics       Date:  2017-07-22       Impact factor: 11.556

Review 8.  Therapeutic approaches for corneal neovascularization.

Authors:  Sepehr Feizi; Amir A Azari; Sharareh Safapour
Journal:  Eye Vis (Lond)       Date:  2017-12-10

9.  Ex Vivo-Induced Bone Marrow-Derived Myeloid Suppressor Cells Prevent Corneal Allograft Rejection in Mice.

Authors:  Jun Zhu; Takenori Inomata; Keiichi Fujimoto; Koichiro Uchida; Kenta Fujio; Ken Nagino; Maria Miura; Naoko Negishi; Yuichi Okumura; Yasutsugu Akasaki; Kunihiko Hirosawa; Mizu Kuwahara; Atsuko Eguchi; Hurramhon Shokirova; Ai Yanagawa; Akie Midorikawa-Inomata; Akira Murakami
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-06-01       Impact factor: 4.799

10.  Pathological conversion of regulatory T cells is associated with loss of allotolerance.

Authors:  Jing Hua; Takenori Inomata; Yihe Chen; William Foulsham; William Stevenson; Tina Shiang; Jeffrey A Bluestone; Reza Dana
Journal:  Sci Rep       Date:  2018-05-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.